David Lamont.
Department of Diabetes & Endocrinology
CSL Behring
Austria
Biography
David Lamont was appointed as Chief Financial Officer in January 2016. As Chief Financial Officer, he is responsible for managing the financial aspects of CSL’s strategy which includes financial planning and reporting, capital management, tax, treasury and investor relations. Immediately prior to joining CSL, he was the Chief Financial Officer and an Executive Director at MMG since 2010. Prior to this, David served as CFO for several leading multinational public companies across a range of industries since 1999 – including MMG Limited, Oz Minerals Limited, PaperlinX Limited, BHP Billiton’s Energy Coal and Carbon Steel Materials divisions and Incitec Pivot Limited. David holds a Bachelor of Commerce degree and is a qualified Chartered Accountant and a member of the Institute of Chartered Accountants (Australia).
Research Interest
Research, Pharmaceuticals, Biotechnology, Healthcare, Medical Science
